Combined with chemotherapy and immunotherapy, AstraZeneca’s Calquence reduced the risk of disease progression or death by 27% compared to placebo and chemoimmunotherapy in first-line mantle …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
What You Should Know: – Abridge, a leader in generative AI for clinical documentation, announced an enterprise-wide agreement with The University of Vermont Health Network.
Margaret Anderson, Managing Director at Deloitte Consulting LLP In response to the COVID-19 pandemic, the biomedical community took on the task of developing and deploying
Patriarchy isn’t a word that Ophira Ginsburg expected to be at the center of her work as a cancer researcher but, like an infection, it